Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan.

Content Provider	Europe PMC
Author	Hayakawa, Satoshi Komine‐Aizawa, Shihoko Takada, Kazuhide Kimura, Tadashi Yamada, Hideto
Abstract	AbstractThe current COVID‐19 pandemic is a global concern. The recent introduction of vaccines has provided a reason for hope, but new problems, such as vaccine hesitancy, have arisen. One of the most important of these issues is the safety of vaccines for pregnant women. In this article, we collected worldwide indications for vaccination, including women who are pregnant or who wish to become pregnant, and reports of adverse reactions to COVID‐19 vaccination. The Japan Society of Obstetrics and Gynecology and the Japanese Society of Infectious Diseases in Obstetrics and Gynecology have published recommendations for the vaccination of pregnant women with a COVID‐19 vaccine. The guidelines are as follows: (1) pregnant women should not be excluded from vaccination; (2) informed consent should be obtained before vaccination; (3) healthcare workers and pregnant women with complications such as diabetes, hypertension, and obesity should be vaccinated preferentially; (4) vaccination should be avoided until 12 weeks of gestation during organogenesis; (5) spouse and family members should be vaccinated actively; and (6) nursing mothers are not particularly affected. This policy has been adopted in government guidelines. Additional efforts should be made to protect pregnant women from infection and severe illness with COVID‐19 by eliminating vaccine hesitancy.
Related Links	https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC8251375&blobtype=pdf
Page Count	7
ISSN	13418076
Journal	The Journal of Obstetrics and Gynaecology Research [J Obstet Gynaecol Res]
Volume Number	47
DOI	10.1111/jog.14748
PubMed Central reference number	PMC8251375
Issue Number	6
PubMed reference number	33754418
e-ISSN	14470756
Language	English
Publisher	John Wiley & Sons Australia, Ltd
Publisher Date	2021-03-23
Publisher Place	Kyoto, Japan
Access Restriction	Open
Rights License	This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. © 2021 Japan Society of Obstetrics and Gynecology.
Subject Keyword	adverse effects COVID‐19 pregnancy vaccine
Content Type	Text
Resource Type	Article
Subject	Obstetrics and Gynecology